Perfusionists are specialized healthcare professionals responsible for operating and managing the heart-lung machine during surgeries, particularly those that require cardiopulmonary bypass. These machines take over the functions of the heart and lungs during procedures like heart surgery, allowing the medical team to operate on a still heart. Perfusionists closely monitor the patient's circulation, blood pressure, and oxygen levels, making real-time adjustments to ensure the patient remains stable. Their precision and ability to respond quickly to any changes during surgery are critical to the success of these complex procedures. They must also be prepared for unexpected challenges, ensuring the patient’s safety throughout the operation. Their expertise can often make the difference between life and death in high-risk surgeries.
Apart from the operating room, perfusionists are also involved in managing blood flow during organ transplantation, ensuring that organs are properly preserved and transported for transplant. They play a vital role in supporting the patient’s circulatory needs during high-risk procedures, working in close coordination with surgeons, anesthesiologists, and nurses. With a high level of expertise, perfusionists are instrumental in providing vital support in critical care settings. By continually adapting to evolving medical technologies and techniques, perfusionists ensure that patients receive the best possible care, contributing to improved surgical outcomes and recovery.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India